R
Roche
Doing Now What Patients Need Next
Basel, Switzerland (US: South SF, Indianapolis)
100,000+
About Roche
Industry:
Pharmaceuticals/Diagnostics
Founded:
1896
Founders:
Fritz Hoffmann-La Roche
Status:
Public (SWX: ROG)
Funding & Growth
Total Raised:
N/A
Valuation:
$230B+ market cap
Stage:
Public
Key Investors:
Public markets
✓ Pros
- • Combined pharma and diagnostics strength
- • Genentech subsidiary for US pharma
- • Leader in personalized healthcare
- • Strong scientific culture
- • Good work-life balance
✗ Cons
- • Swiss headquarters (timezone)
- • Large company bureaucracy
- • Some overlap with Genentech
- • Complex matrix organization